Technical Specifications
Compound Name: Epithalon (Epitalon)
Quantity: 10mg per vial
Format: Lyophilized peptide powder
Peptide Length: 4 amino acids
Sequence: Ala-Glu-Asp-Gly
Molecular Weight: Approximately 390.35 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational peptide – laboratory research use only
Epithalon 10mg Canada is supplied as a lyophilized synthetic tetrapeptide intended exclusively for laboratory and analytical applications. Each vial contains 10 milligrams of the peptide prepared under controlled handling and quality verification standards appropriate for research material distribution.
This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada when supplied in research format.
Research Overview
Epithalon, also known as Epitalon, is a synthetic tetrapeptide derived from a naturally occurring peptide complex associated with the pineal gland. It has been studied in experimental models exploring cellular ageing, telomerase activity, and endocrine signalling pathways.
Research involving Epithalon 10mg Canada typically focuses on telomere biology, gene expression regulation, and circadian rhythm–related mechanisms in controlled laboratory environments. Scientific literature describes Epithalon as a peptide investigated in cell culture and animal studies for its effects on cellular proliferation markers and chromosomal stability.
Preclinical studies have evaluated Epithalon in vitro using models that measure telomerase expression and telomere length maintenance. Laboratory investigations frequently assess changes in gene transcription, DNA replication markers, and oxidative stress parameters in experimental systems.
Epithalon 10mg Canada is supplied strictly for research purposes. All references to biological pathways reflect investigational findings derived from laboratory and exploratory research contexts and do not imply authorized clinical application of the research-grade material.
Mechanism Overview
Epithalon is composed of four amino acids (Ala-Glu-Asp-Gly). In laboratory studies, it has been investigated for its potential interaction with nuclear regulatory pathways associated with telomerase expression.
Experimental models suggest that short peptides, such as Epithalon, may influence transcriptional activity in genes related to cellular replication and ageing. Researchers studying Epithalon 10mg Canada typically analyze telomerase reverse transcriptase (TERT) expression, telomere length markers, and cell cycle regulatory proteins under controlled conditions.
Epithalon has also been examined in research on melatonin-related endocrine signalling, given its origins in pineal peptide research. Mechanistic descriptions remain confined to preclinical and investigational data and are presented for educational purposes only.
Clinical Development Context
Epithalon has been studied in limited clinical and observational research settings, primarily within Eastern European scientific programmes. Published literature includes exploratory studies examining biological ageing markers and endocrine parameters under controlled conditions.
However, Epithalon 10mg, supplied in research-grade format, is categorized strictly as an investigational laboratory compound. It is distinct from any authorized pharmaceutical preparation and is not approved by Health Canada as a prescription medication or consumer health product when provided as a research material.
Ongoing academic interest in peptide-based ageing research continues within molecular biology and gerontology research institutions.
Regulatory Status in Canada
Epithalon 10mg Canada is classified as an investigational research peptide. It is not authorized by Health Canada as a therapeutic drug, natural health product, or over-the-counter medication when supplied in research format.
The peptide is provided exclusively for laboratory and analytical purposes and is not intended for human or veterinary administration.
Handling, storage, and study of Epithalon 10mg in Canada must comply with applicable federal and provincial Canadian regulations governing chemical and biological research materials. Laboratories and research institutions are responsible for maintaining regulatory compliance.
Molecular and Structural Notes
Epithalon is a short linear tetrapeptide with a molecular weight of approximately 390.35 g/mol. Its minimal amino acid sequence allows researchers to examine small peptide motifs and their potential regulatory influence in experimental systems.
Due to its size and simple structure, Epithalon is synthesized by solid-phase peptide synthesis and purified by high-performance liquid chromatography (HPLC). Epithalon 10mg Canada is analytically characterized using HPLC and mass spectrometry to confirm identity and purity before distribution.
The lyophilized format supports peptide stability during storage when maintained under appropriate laboratory conditions.
Frequently Asked Questions
What is Epithalon 10mg Canada studied for in research?
Epithalon 10mg Canada is being studied in laboratory settings to investigate telomerase activity, gene expression regulation, and cellular ageing pathways.
Is Epithalon approved for medical use in Canada?
Health Canada does not authorize research-grade Epithalon for therapeutic or consumer use.
What type of peptide is Epithalon?
It is a synthetic tetrapeptide studied in molecular biology and ageing research contexts.
Does Epithalon 10mg Canada contain additives?
Unless specified in the batch documentation, the vial contains only the lyophilized peptide compound.
Can Epithalon 10mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.
Educational Disclaimer
Epithalon 10mg Canada is an investigational research peptide supplied solely for laboratory and analytical use. It is not approved by Health Canada as a medication, therapeutic agent, or consumer product when provided in research-grade form.
The information provided on this page is educational and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.
Study and handling of Epithalon 10mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.




Reviews
There are no reviews yet